PFAS cost per signed retainer
PFAS personal injury (non-AFFF residential) carries a cost per signed retainer of $7,500–$11,500 in Q1 2026, current as of March 31, 2026, at a 4–8% signed rate and a very high qualification tier. Litigation status (verified November 17, 2026): active federal mdl. Sample size and confidence interval for this row are not available; the reason is stated on each figure below rather than omitted.
Data as of Updated Q1 2026 releaseLatest published release; the next quarterly release has not been published yet
PFAS litigation status & sources
Active federal MDLStatus verified on against primary sources · next check due
As of Nov 2026, PFAS injury claims tied to firefighting foam are centralized in AFFF MDL 2873 (D.S.C.), with 15,270 pending actions. 3M announced a personal-injury settlement on Nov 3, 2026; claims against other manufacturers continue.
- Proceeding
- MDL 2873 (Aqueous Film-Forming Foams Products Liability Litigation) (D.S.C.)
- Richard M. Gergel
- Pending actions
- 15,270
- JPML Pending MDL Dockets by District, report date 2026-11-02
Key dates
- EPA finalized the first national drinking-water standards for six PFAS, including 4.0 ppt limits for PFOA and PFOS.
- EPA proposed extending PFOA/PFOS compliance to 2031 and rescinding limits for PFHxS, PFNA, HFPO-DA and the hazard-index mixture.
- 3M announced on Nov 3, 2026 a resolution of PFAS personal-injury claims centered on the AFFF MDL, with a $7.35 billion nominal commitment through 2034, subject to participation terms.
Sources
- JPMLJPML Pending MDL Dockets by District (report date Nov 2, 2026)
- Government3M Form 8-K Exhibit 99.1: 3M Reaches Broad Resolution of AFFF Personal Injury Litigation (Nov 3, 2026)
- GovernmentEPA: Per- and Polyfluoroalkyl Substances (PFAS) drinking water regulation
Our other PFAS pages
Marketing information for law firms, not legal advice. Litigation status changes; confirm filing posture, case criteria and deadlines with counsel before launching or continuing a campaign. How we source and date this: editorial standards.
CPR range · Q1 2026
$7,500 – $11,500
Median: n/a — Per-tort medians are not published. The dataset carries the interquartile low and high bounds for each tort; only the national median is published as a point value.
Signed rate
4–8%
Share of exclusive leads that become signed retainers.
Qualification tier
Very High
Relative difficulty of clearing this tort's qualifying criteria.
Litigation status
Active federal MDL
Verified November 17, 2026 against primary sources.
Sample size
n/a
Per-tort sample sizes are not broken out in the published dataset. The panel total (140 firms, $180M of annual mass tort lead spend across 16 active tort categories) is published at the panel level only, so the number of firms and the spend basis behind any single row cannot be stated.
Confidence interval
n/a
Not computable from the published dataset. Benchmarks are published as trimmed interquartile ranges, and the per-observation values a confidence interval requires are not retained in the published figures.
Unverified
No third party has reviewed this methodology or the underlying data. Mass Tort Marketing Agency sells the leads these figures price.
What third-party verification would involvePFAS CPR over time
The series for PFAS starts at Q1 2026. Mass Tort Marketing Agency holds one published quarter of per-tort data for this tort, so there is no trend line to draw yet — the single point is shown below, and a second point will appear when the next quarter publishes.
| Quarter | CPR low | CPR high | Note |
|---|---|---|---|
| Q4 2024 | n/a | n/a | No per-tort breakdown for Q4 2024 is held in the dataset. Only the national median is held for that quarter, which is why the per-tort trend series begins at Q1 2026. |
| Q1 2026 | $7,500 | $11,500 | Published. |
What qualifies a PFAS claimant
Documented PFAS exposure through contaminated drinking water or consumer products, plus a specific PFAS-linked cancer or disease diagnosis. Distinct from AFFF occupational-exposure claims.
Falloff: n/a — Not published for this tort. The source dataset does not state a numeric falloff range for PFAS personal injury.
Active — what that means for acquisition
Active and the highest-CPR tort in the benchmark, with the lowest signed rate of any active tort because criteria require both exposure documentation and highly specific medical documentation. This is a specialty tort: firms operating it successfully are geographically focused on known-contamination zones (specific PFAS-impacted water districts, specific consumer-product batches) rather than running national campaigns. A geographically-targeted campaign in a confirmed contamination zone can achieve CPR 30-40% below the national PFAS benchmark; a national campaign rarely achieves even the upper-band benchmark.
PFAS cost per lead
This dataset does not publish a cost-per-lead figure for PFAS, and no CPL value is shown here rather than being derived from the CPR band. The two are related by the signed rate — CPL is approximately CPR × signed rate — but running that multiplication against a published interquartile band produces a number that looks measured and is not, so it is left out. What the benchmark does state is the signed rate: 4–8% of exclusive PFAS leads become signed retainers that survive the 30-day falloff window. If you have your own CPL from a vendor quote, that signed rate is the multiplier that turns it into a comparable CPR.
Download this row
How to cite this page
Suggested citation:
Mass Tort Marketing Agency. "PFAS personal injury (non-AFFF residential) cost per signed retainer." Q1 2026 CPR Benchmark, published April 24, 2026. https://www.masstortmarketingagency.com/benchmarks/pfas-personal-injury
- Canonical URL:
- https://www.masstortmarketingagency.com/benchmarks/pfas-personal-injury
- License:
- CC BY 4.0 — reuse permitted with attribution to Mass Tort Marketing Agency CPR Benchmark, https://www.masstortmarketingagency.com/benchmarks/
Citing a number that must stay stable? Point at a dated snapshot instead of the live page — snapshot files never change.
